Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.
The net benefit for detecting clinically significant prostate cancer (csPC) is greater with Stockholm3 vs PSA, according to findings from a large prospective study published in th ...
Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice. We’ve ...
Next month, as part of the 1012-mile, 44-day gruelling feat to raise awareness and vital funds, the charity is inviting local ...
Smart PSA boosted targeted screening and found more aggressive prostate cancers in Black men in Chicago trials.
By HealthDay Staff HealthDay ReporterFRIDAY, June 26, 2026 (HealthDay News) — A next-generation blood test could improve ...
(Aging Untold) — Prostate cancer is one of the most common cancers for men in the United States, but deciding when to get screened isn’t always clear. While a PSA blood test can help find prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results